These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23249852)

  • 1. Interaction between oseltamivir and herbal medicines used for treating avian influenza.
    Yang MS; Law FC; Wong RN; Mak NK; Wei XY
    Hong Kong Med J; 2012 Dec; 18 Suppl 6():34-6. PubMed ID: 23249852
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of potential herb-drug interactions between oseltamivir and commonly used anti-influenza Chinese medicinal herbs.
    Zhang Y; Lyu C; Fong SYK; Wang Q; Li C; Ho NJ; Chan KS; Yan X; Zuo Z
    J Ethnopharmacol; 2019 Oct; 243():112097. PubMed ID: 31325600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese herbal therapy as a treatment option for H1N1 influenza.
    Wang CZ; Li P; Yuan CS
    Ann Intern Med; 2012 Jan; 156(2):166; author reply 166-7. PubMed ID: 22250153
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical characteristics and treatment of community outbreaks of the new influenza A (H1N1) infection].
    Wang P; Zhu ML; Song HJ; Xiao Q; Kong XC; Peng WH; Xing SL; Guo AM
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):419-21. PubMed ID: 20979812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal Medicine Treatment for Influenza: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Choi M; Lee SH; Chang GT
    Am J Chin Med; 2020; 48(7):1553-1576. PubMed ID: 33167671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience.
    Nguyen-Van-Tam JS
    J Antimicrob Chemother; 2010 Apr; 65 Suppl 2(Suppl 2):ii3-ii4. PubMed ID: 20215133
    [No Abstract]   [Full Text] [Related]  

  • 7. Probenecid with oseltamivir for human influenza A (H5N1) virus infection?
    Howton JC
    N Engl J Med; 2006 Feb; 354(8):879-80. PubMed ID: 16495407
    [No Abstract]   [Full Text] [Related]  

  • 8. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
    Taylor WR; Thinh BN; Anh GT; Horby P; Wertheim H; Lindegardh N; de Jong MD; Stepniewska K; Hanh TT; Hien ND; Bien NM; Chau NQ; Fox A; Ngoc NM; Crusat M; Farrar JJ; White NJ; Ha NH; Lien TT; Trung NV; Day N; Binh NG
    PLoS One; 2008; 3(10):e3410. PubMed ID: 18923671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
    Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
    Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has oseltamivir been shown to be effective for treatment of H5N1 influenza?
    Couch RB; Davis BR
    J Infect Dis; 2010 Oct; 202(8):1149-51. PubMed ID: 20831386
    [No Abstract]   [Full Text] [Related]  

  • 11. H5N1 virus resistant to antiviral drug.
    Chen HL; Guan Y
    Hong Kong Med J; 2015 Jun; 21 Suppl 4():12-3. PubMed ID: 26157095
    [No Abstract]   [Full Text] [Related]  

  • 12. Assay to detect H5N1 oseltamivir resistance.
    Suwannakarn K; Chutinimitkul S; Payungporn S; Chieochansin T; Theamboonlers A; Amonsin A; Damrongwatanapokin S; Mai le Q; Hanh NH; Poovorawan Y
    Emerg Infect Dis; 2006 Dec; 12(12):1995-6. PubMed ID: 17354342
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
    Nabeshima S; Kashiwagi K; Ajisaka K; Masui S; Takeoka H; Ikematsu H; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):534-43. PubMed ID: 22350323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tamiflu resistance].
    Nau JY
    Rev Med Suisse; 2006 Dec; 2(91):2886. PubMed ID: 17236332
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.
    Kubo T; Nishimura H
    Phytomedicine; 2007 Feb; 14(2-3):96-101. PubMed ID: 17141491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
    Sidwell RW; Barnard DL; Day CW; Smee DF; Bailey KW; Wong MH; Morrey JD; Furuta Y
    Antimicrob Agents Chemother; 2007 Mar; 51(3):845-51. PubMed ID: 17194832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of Tamiflu under pandemic conditions].
    Nau JY
    Rev Med Suisse; 2009 Jul; 5(211):1532. PubMed ID: 19694366
    [No Abstract]   [Full Text] [Related]  

  • 18. [When the Avian virus (H5N1) become resistant to Tamiflu and the resulting consequences].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(48):171. PubMed ID: 16463806
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment options for H5N1: lessons learned from the H1N1 pandemic.
    Reece PA
    Postgrad Med; 2010 Sep; 122(5):134-41. PubMed ID: 20861597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
    Nitsch-Osuch A; Brydak LB; Wardyn AK
    Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.